$140 Million is the total value of EMORY UNIVERSITY's 46 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 46.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | Sell | BEIGENE LTDsponsored adr | $3,221,000 | +50.1% | 19,170 | -12.7% | 2.30% | +24.9% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $3,069,000 | +50.7% | 46,933 | -7.6% | 2.19% | +25.5% |
| STX | Sell | SEAGATE TECHNOLOGY PLC | $2,412,000 | +22.3% | 41,216 | -12.6% | 1.72% | +1.7% |
| FOX | Sell | TWENTY FIRST CENTY FOX INCcl b | $2,081,000 | -6.3% | 57,218 | -12.0% | 1.49% | -22.0% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $2,010,000 | +12.4% | 41,610 | -8.4% | 1.44% | -6.5% |
| AWI | Sell | ARMSTRONG WORLD INDS INC NEW | $1,928,000 | -11.4% | 34,238 | -4.8% | 1.38% | -26.3% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,920,000 | -13.2% | 47,886 | -24.0% | 1.37% | -27.8% |
| SPY | Sell | SPDR S&P 500 ETF TRtr unit | $229,000 | -3.4% | 872 | -1.9% | 0.16% | -19.2% |
| AAPL | Exit | APPLE INC | $0 | – | -1,359 | -100.0% | -0.20% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -518,223 | -100.0% | -1.28% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -602,883 | -100.0% | -1.44% | – |
| TSRO | Exit | TESARO INC | $0 | – | -20,407 | -100.0% | -1.45% | – |
| AAAP | Exit | ADVANCED ACCELERATOR APPLICsponsored ads | $0 | – | -22,538 | -100.0% | -1.58% | – |
| BKR | Exit | BAKER HUGHES A GE COcl a | $0 | – | -58,965 | -100.0% | -1.60% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -383,768 | -100.0% | -1.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.